UNIGE document Scientific Article
previous document  unige:2544  next document
add to browser collection

The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee

Chen, Robert
Cros, Didier
Ziemann, Ulf
Curra, Antonio
Di Lazzaro, Vincenzo
Lefaucheur, Jean-Pascal
Mills, Kerry
show hidden authors show all authors [1 - 11]
Published in Clinical Neurophysiology. 2008, vol. 119, no. 3, p. 504-32
Abstract The review focuses on the clinical diagnostic utility of transcranial magnetic stimulation (TMS). The central motor conduction time (CMCT) is a sensitive method to detect myelopathy and abnormalities may be detected in the absence of radiological changes. CMCT may also detect upper motor neuron involvement in amyotrophic lateral sclerosis. The diagnostic sensitivity may be increased by using the triple stimulation technique (TST), by combining several parameters such as CMCT, motor threshold and silent period, or by studying multiple muscles. In peripheral facial nerve palsies, TMS may be used to localize the site of nerve dysfunction and clarify the etiology. TMS measures also have high sensitivity in detecting lesions in multiple sclerosis and abnormalities in CMCT or TST may correlate with motor impairment and disability. Cerebellar stimulation may detect lesions in the cerebellum or the cerebellar output pathway. TMS may detect upper motor neuron involvement in patients with atypical parkinsonism and equivocal signs. The ipsilateral silent period that measures transcallosal inhibition is a potential method to distinguish between different parkinsonian syndromes. Short latency afferent inhibition (SAI), which is related to central cholinergic transmission, is reduced in Alzheimer's disease. Changes in SAI following administration of cholinesterase inhibitor may be related to the long-term efficacy of this treatment. The results of MEP measurement in the first week after stroke correlate with functional outcome. We conclude that TMS measures have demonstrated diagnostic utility in myelopathy, amyotrophic lateral sclerosis and multiple sclerosis. TMS measures have potential clinical utility in cerebellar disease, dementia, facial nerve disorders, movement disorders, stroke, epilepsy, migraine and chronic pain.
Keywords Electric Stimulation/methodsElectromyography/methods/utilizationEvoked Potentials, Motor/physiologyHumansNervous System Diseases/diagnosis/physiopathologyNeural Conduction/physiologyTranscranial Magnetic Stimulation/methods/utilization
PMID: 18063409
Full text
Article (Author postprint) (853 Kb) - document accessible for UNIGE members only Limited access to UNIGE
(ISO format)
CHEN, Robert et al. The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. In: Clinical Neurophysiology, 2008, vol. 119, n° 3, p. 504-32. https://archive-ouverte.unige.ch/unige:2544

237 hits

1 download


Deposited on : 2009-08-28

Export document
Format :
Citation style :